Skip to main content
Premium Trial:

Request an Annual Quote

Curetis Unyvero BCU Blood Culture Application Cartridge

Curetis has launched its new Unyvero BCU Blood Culture application cartridge for broad commercial rollout. The cartridge features a unique and differentiated test panel covering more than 100 diagnostic targets, including tests detecting Gram-positive and Gram-negative bacteria, fungi, mycobacteria, and 16 antibiotic resistance biomarkers. It can test a range of samples from positively flagged blood culture to bottles inoculated with blood from patients with suspected bloodstream infections. The BCU application cartridge delivers comprehensive results within four to five hours, and is compatible with the most common commercial blood culture systems.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.